|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| A61K 31/16 |
| (11) | Patento numeris | 2195462 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08830209.6 |
| Europos patento paraiškos padavimo data | 2008-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-06-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/076147 |
| Data | 2008-09-12 |
| (87) | Numeris | WO 2009/036257 |
| Data | 2009-03-19 |
| (30) | Numeris | Data | Šalis |
| 972196 P | 2007-09-13 | US |
| (72) |
LAVEDAN, Christian, US
POLYMEROPOULOS, Mihael H., US
BIRZNIEKS, Gunther, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
9605 Medical Center Drive, Suite 300, Rockville, MD 20850,
US
|
| (54) | PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE |
| PREDICTION OF SLEEP PARAMETER AND RESPONSE TO SLEEP-INDUCING COMPOUND BASED ON PER3 VNTR GENOTYPE |